0.21
전일 마감가:
$0.2112
열려 있는:
$0.2016
하루 거래량:
3.82M
Relative Volume:
0.82
시가총액:
$13.04M
수익:
$69.49M
순이익/손실:
$-21.13M
주가수익비율:
-0.3236
EPS:
-0.649
순현금흐름:
$-14.46M
1주 성능:
-15.93%
1개월 성능:
-16.83%
6개월 성능:
-59.62%
1년 성능:
-50.05%
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health Inc
|
0.21 | 13.04M | 69.49M | -21.13M | -14.46M | -0.649 |
|
MCK
Mckesson Corp
|
763.91 | 89.44B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
281.10 | 54.69B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
228.91 | 53.61B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
80.10 | 9.12B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.36 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health inks agreement to deploy AI-powered voice platform - scanx.trade
Cosmos Health (COSM) Implements AI-Powered Call Center for Enhan - GuruFocus
Cosmos Health deploys AI call center for customer support By Investing.com - Investing.com Nigeria
Cosmos Health deploys AI call center for customer support - Investing.com
Cosmos Health Inc. Announces AI-Powered Call Center Deployment for CosmoFarm Customer Communications - Quiver Quantitative
Cosmos Health Signs Agreement to Deploy Artificial - GlobeNewswire
Cosmos Health bets on AI to handle orders and customer calls - Stock Titan
Cosmos Health Inc (COSM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cosmos Health (COSM) Secures Significant Manufacturing Contracts - GuruFocus
Cosmos Health secures 25M unit manufacturing orderbook - Investing.com UK
Cosmos Health secures 25M unit manufacturing orderbook By Investing.com - Investing.com Nigeria
Cosmos Health Reports Cana Laboratories Secures Over 25 Million Units in Multi-Year Contract Manufacturing Orderbook - Quiver Quantitative
Cosmos Health Builds Contract Manufacturing Orderbook to - GlobeNewswire
Cosmos Health builds 25M-unit contract manufacturing book - Stock Titan
Cosmos Health CEO addresses shareholders amid stock decline By Investing.com - Investing.com Nigeria
CosmoFarm's Robotic Rise: A Lifeline for Financially Strained Cosmos Health? - BriefGlance
Cosmos Health Reports Record Q2 Revenue for CosmoFarm, Exceeds $60 Million Annualized Run Rate - Quiver Quantitative
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cosmos Health enters skincare market with new product line By Investing.com - Investing.com Australia
Cosmos Health enters skincare market with new product line - Investing.com
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States - 富途牛牛
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Inc (COSM) Valuation: PE, PB & Fair Value Analysis - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Cosmos Health Inc (COSM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cosmos Health signs five-year manufacturing deal with Pharmex - Investing.com
Cosmos Health signs five-year manufacturing deal with Pharmex By Investing.com - Investing.com Nigeria
Cosmos HealthEnters Five-Year Contract Man - Moomoo
Cosmos Health lands five-year deal to make 2.86 million drug units - Stock Titan
Cosmos Health (COSM) CFO swaps $42K company debt for 168,135 shares - Stock Titan
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products - Sahm
$Cosmos Health (COSM.US)$ finally see a smiley face upwards movement - Moomoo
Cosmos Health Introduces Four 18 Series Products with Projected Annualized Revenue and Gross Profit in the United States - marketscreener.com
Cosmos Health Provides Update on United States Portfolio; - GlobeNewswire
Cosmos Health projects $22.7M revenue from U.S. product line - Investing.com UK
Cosmos Health projects $22.7M revenue from U.S. product line By Investing.com - Investing.com Nigeria
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit - marketscreener.com
$Cosmos Health (COSM.US)$ just waiting to see better volume - Moomoo
Why Tower Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Cosmos Health (COSM) Secures New Contract Manufacturing Orders - GuruFocus
Cosmos Health Gets New Contract Manufacturing Orders for 253,657 Units Across Multiple Medicines - marketscreener.com
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines - GlobeNewswire
Cosmos Health Inc. - Via Ritzau
Cosmos Health Stock (COSM) Opinions on EU Expansion and Antiseptic Sales Growth - Quiver Quantitative
Cosmos Health (NASDAQ: COSM) CEO swaps $45K company debt for shares - Stock Titan
Cosmos Health sets three-year targets for antiseptic brands By Investing.com - Investing.com Australia
Cosmos Health sets three-year targets for antiseptic brands - Investing.com
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cosmos Health Inc 주식 (COSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
자본화:
|
볼륨(24시간):